Fitness7 months ago
Subgroup and Toxicity Analyses Favor Zanubrutinib Vs Ibrutinib in CLL
Lori A. Leslie, MD Director, Indolent lymphoma and Chronic Lymphocytic Leukemia Research Programs John Theurer Cancer Center Assistant Professor, Hackensack Meridian School of Medicine Hackensack, NJ...
